Chronic Myelogenous Leukemia (CML)Symptoms, Doctors, Treatments, Advances & More
Chronic Myelogenous Leukemia (CML) Overview
Learn About Chronic Myelogenous Leukemia (CML)
View Main Condition: Leukemia
Chronic myelogenous leukemia (CML) is cancer that starts inside the bone marrow. This is the soft tissue in the center of bones that helps form all blood cells.
CML causes an uncontrolled growth of immature and mature cells that make a certain type of white blood cell called myeloid cells. The diseased cells build up in the bone marrow and blood.
CML; Chronic myeloid leukemia; CGL; Chronic granulocytic leukemia; Leukemia - chronic granulocytic
The cause of CML is usually related to an abnormal chromosome called the Philadelphia chromosome.
Radiation exposure can increase the risk of developing CML. Radiation exposure can be from radiation treatments used in the past to treat thyroid cancer or Hodgkin lymphoma or from a nuclear disaster.
It takes many years to develop leukemia from radiation exposure. Most people treated for cancer with radiation do not develop leukemia. And most people with CML have not been exposed to radiation.
CML most often occurs in middle-age adults and can also occur in children.
CML is grouped into phases:
- Chronic
- Accelerated
- Blast crisis
The chronic phase can last for months or years. The disease may have few or no symptoms during this time. Most people are diagnosed during this stage, when they have blood tests done for other reasons.
The accelerated phase is a more dangerous phase. Leukemia cells grow more quickly. Common symptoms include fever (even without infection), bone pain, and a swollen spleen.
Untreated CML leads to the blast crisis phase. Bleeding and infection may occur due to bone marrow failure.
Other possible symptoms of a blast crisis include:
- Bruising
- Excessive sweating (night sweats)
- Fatigue
- Fever
- Pressure under the lower left ribs from a swollen spleen
- Rash -- small pinpoint red marks on the skin (petechiae)
- Weakness
Medicines that target the abnormal protein made by the Philadelphia chromosome are often the first treatment for CML. These medicines are almost always taken as pills. People treated with these medicines often go into remission quickly and can stay in remission for many years. In some people, deep remissions can be obtained and medicine may be stopped without the leukemia returning.
Sometimes, chemotherapy is used first to reduce the white blood cell count if it is very high at diagnosis.
The blast crisis phase is very difficult to treat. This is because there is a very high count of immature white blood cells (leukemia cells) that are resistant to treatment.
UT MD Anderson Cancer Center
Tapan Kadia is a Hematologist practicing medicine in Cary, North Carolina. Dr. Kadia is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Ellin Berman is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Berman is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Berman is currently accepting new patients.
Office
Hagop Kantarjian is an Oncologist practicing medicine in Houston, Texas. Dr. Kantarjian is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Splenectomy.
You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.
Targeted medicines, such as tyrosine kinase inhibitors, have greatly improved the outlook for people with CML. Most people can remain in remission, assessed typically by blood tests, for many years, and potentially for life, while on this medicine.
A stem cell or bone marrow transplant is often considered in people whose disease comes back or gets worse while taking the medicines. A transplant may also be recommended for people who are diagnosed in the accelerated phase or blast crisis.
Blast crisis can lead to complications, including infection, bleeding, fatigue, unexplained fever, and kidney problems. Chemotherapy can have serious side effects, depending on the medicines used.
Avoid exposure to radiation when possible.
Summary: In a multinational, multicenter, single-arm, open-label and Phase III Radotinib clinical study, chronic phase Ph+ chronic myeloid leukemia patients with failure or intolerance to previous TKIs therapy including Imatinib will be recruited. In this phase 3 study, 173 subjects are expected to be enrolled in a single arm with the administration of Radotinib 400mg twice daily, which includes 10% of dro...
Summary: The aim of this study is to assess the real-world effectiveness of asciminib in Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients who were either newly diagnosed or previously treated with one ATP-competitive tyrosine kinase inhibitor (TKI).
Published Date: January 29, 2026
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Kantarjian H, Cortes J. Chronic myeloid leukemia. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 98.
National Cancer Institute website. Chronic myelogenous leukemia treatment (PDQ) health professional version. www.cancer.gov/types/leukemia/hp/cml-treatment-pdq. Updated March 13, 2025. Accessed April 7, 2026.
National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology: (NCCN guidelines).Chronic myeloid leukemia. Version 2. 2027. www.nccn.org/professionals/physician_gls/pdf/cml.pdf. Updated July 10, 2026. Accessed July 23, 2026.
Radich J. Chronic myeloid leukemia. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 170.